Generating prophylactic immunity against arboviruses in vertebrates and invertebrates

• Published in: Nature reviews. Immunology Vol. 24; no. 9; pp. 621 - 636
• Main Authors: Rawle, Daniel J., Hugo, Leon E., Cox, Abigail L., Devine, Gregor J., Suhrbier, Andreas
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.09.2024; Nature Publishing Group
• Subjects: 631/250/24/590; 631/250/2520; 631/250/255/2514; 631/326/596/2557; 692/699/255/2514; Animals; Antiviral drugs; Aquatic insects; Arbovirus Infections - immunology; Arbovirus Infections - prevention & control; Arboviruses - immunology; Biomedical and Life Sciences; Biomedicine; Culicidae; Humans; Immune response; Immune system; Immunity; Immunity (Disease); Immunology; Invertebrates; Invertebrates - immunology; Mosquito Vectors - immunology; Mosquito Vectors - virology; Mosquitoes; Review Article; Vaccines; Vector-borne diseases; Vectors; Venezuelan equine encephalitis; Vertebrates; Vertebrates - immunology; Viral Vaccines - immunology; Viruses; Yellow fever
• ISSN: 1474-1733; 1474-1741; 1474-1741
• DOI: 10.1038/s41577-024-01016-6

The World Health Organization recently declared a global initiative to control arboviral diseases. These are mainly caused by pathogenic flaviviruses (such as dengue, yellow fever and Zika viruses) and alphaviruses (such as chikungunya and Venezuelan equine encephalitis viruses). Vaccines represent key interventions for these viruses, with licensed human and/or veterinary vaccines being available for several members of both genera. However, a hurdle for the licensing of new vaccines is the epidemic nature of many arboviruses, which presents logistical challenges for phase III efficacy trials. Furthermore, our ability to predict or measure the post-vaccination immune responses that are sufficient for subclinical outcomes post-infection is limited. Given that arboviruses are also subject to control by the immune system of their insect vectors, several approaches are now emerging that aim to augment antiviral immunity in mosquitoes, including Wolbachia infection, transgenic mosquitoes, insect-specific viruses and paratransgenesis. In this Review, we discuss recent advances, current challenges and future prospects in exploiting both vertebrate and invertebrate immune systems for the control of flaviviral and alphaviral diseases. In this Review, the authors discuss recent advances, current challenges and future prospects in exploiting both vertebrate and invertebrate immune systems for the control of flaviviral and alphaviral diseases.